ICH Project Briefing on ICH M13B "Bioequivalence of Immediate Release Oral Solid Dosage Forms - Additional Content Biowaiver" draft guideline
Mar 21, 2025
The ICH M13 Expert Working Group (EWG) has been studying to develop a guideline for bioequivalence of immediate-release oral solid dosage forms and M13A reached Step 4 on July 23, 2024. Now, the draft ICH M13B guideline has reached Step 2 as of March 13, 2025, and has been published on the official ICH website. In Japan, a call for public comments on the draft ICH M13B "Bioequivalence of Immediate Release Oral Solid Dosage Forms - Additional Content Biowaiver" is scheduled to be launched.
In order to promote understanding of the draft guideline and to support the collection of public comments, a briefing session on the draft ICH M13B guideline will be held.
The program and other details of the briefing can be found on the PMDA Website.
The End